Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 25;61(5):2300619.
doi: 10.1183/13993003.00619-2023. Print 2023 May.

Towards a better mucolytic

Burton F Dickey  1 , Christopher M Evans  2
Affiliations
Editorial

Towards a better mucolytic

Burton F Dickey et al. Eur Respir J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: B.F. Dickey reports funding from NIH, NHLBI to study airway mucus dysfunction, and consulting fees from Arrowhead Pharmaceuticals on the treatment of muco-obstructive lung diseases. C.M. Evans reports funding from NIH, NHLBI to study airway mucus dysfunction.

Comment on

References

    1. Fahy JV, Dickey BF: Airway mucus function and dysfunction. N Engl J Med 2010, 363(23):2233–2247. - PMC - PubMed
    1. Hill DB, Button B, Rubinstein M, Boucher RC: Physiology and pathophysiology of human airway mucus. Physiol Rev 2022, 102(4):1757–1836. - PMC - PubMed
    1. Kim V, Evans CM, Dickey BF: Dawn of a New Era in the Diagnosis and Treatment of Airway Mucus Dysfunction. Am J Respir Crit Care Med 2018. - PubMed
    1. Mall MA, Danahay H, Boucher RC: Emerging Concepts and Therapies for Mucoobstructive Lung Disease. Ann Am Thorac Soc 2018, 15(Suppl 3):S216–S226. - PMC - PubMed
    1. Figueira MF, Ribeiro CMP, Button B: Mucus-targeting therapies of defective mucus clearance for cystic fibrosis: A short review. Curr Opin Pharmacol 2022, 65:102248. - PMC - PubMed

LinkOut - more resources